H1B Salary Data

Home › Employers › West Virginia School of Osteopathic Medicine

West Virginia School of Osteopathic Medicine: H-1B salaries and sponsorship

West Virginia School of Osteopathic Medicine filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $113,500.

Applications (LCAs)3
Certified3
Employer addressLewisburg, WV
H-1B dependent employerNo
Median offered salary$113,500
Middle half of salaries$109,254–$125,644
10th–90th percentile$106,706–$132,930

Does West Virginia School of Osteopathic Medicine sponsor H-1B visas?

West Virginia School of Osteopathic Medicine filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on May 12, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Associate Professor2$125,644
Assistant Professor1$105,008

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20231$113,500
FY20252$121,398

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Associate Professor$137,787
E-3 · Level III
Lewisburg, WVMay 12, 2025Jul 21, 2025Certified
Assistant Professor$105,008
Level II
Lewisburg, WVMar 27, 2025Jul 15, 2025Certified
Associate Professor$113,500
Level II
Lewisburg, WVJul 27, 2023Aug 14, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).